This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Medex Inc. Warns Public Of Un-Solicited Email Spam

CHULA VISTA, Calif., Jan. 16, 2013 /PRNewswire/ -- Medex Inc. (OTC Markets Group, Inc.: MDXX) announces today that the Company and its officers wish to warn the public regarding the unauthorized and unsolicited use of company press releases, corporate website domain and information relating to the Company by an unknown party and that such use is illegal spam and strictly prohibited.  Medex Inc. is currently investigating the source of this illegal spam with the assistance of its corporate counsel.  Medex Inc. expressly prohibits the use of spam and demands that the responsible party immediately cease this illegal activity.

Medex Inc. encourages the public to be well informed and to thoroughly research any investment of securities prior to making any financial commitment as well as seek the advice of a licensed broker prior to investing. The Company further cautions the public against relying upon unsolicited emails or phone calls when it comes to investing. Medex Inc. is currently investigating the source of this illegal spam with the assistance of its corporate counsel.

The Company deeply regrets the inconvenience this has caused and apologizes to those whom have been affected.  Medex Inc. has not given any authorization, express or implied, for any company or persons to perform in this manner.  These actions qualify as stock promotion and are classified as illegal marketing tactics.

About Medex Inc.

Medex, Inc. is publicly traded on the OTC Markets Group (MDXX) and is a California based medical support and services Company.  It distributes quality Medicare – Accredited medical equipment and supplies to consumers, medical professionals and insurance carriers.   The Company's vision is to be a pre-eminent medical and equipment supply Company by providing products for people with disabilities, recovering from surgery, in rehabilitation facilities, nursing homes, assisted living centers and the elderly.  For additional information please visit the company's website at http://www.21stsynergymedical.com.

Contact: Investor Relations:1-800-245-7791 Ext. #3 Email: info@21stsynergymedical.comWebsite: www.21stsynergymedical.com

Safe Harbour Statement

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs